Les 10 concurrents nektar.com les plus visités

biomarin.com

Submit a publication data request to inquire about receiving access to de-identified patient-level data collected in clinical trials.

nervgen.com

Investor FAQ Most frequently asked questions and answers Where is NervGen’s stock listed? NervGen trades in Canada on the TSX.V under the symbol NGEN and in the U.S. on the OTCQB under the symbol NGENF. How many NervGen shares are issued and outstanding? Refer to NervGen’s latest filed financial statements for the latest available share […]

tubulis.com

Harnessing the Power of ADCs Our technologies P5 Tubutecan Alco5​ P5 Conjugation​ The Next Generation Conjugation for High DAR ADCs Our P5 Conjugation Technology allows to rapidly generate ultra-stable ADCs with antibody-like biophysical properties and chemical flexibility providing us with the opportunity to develop truly differentiated ADCs More about P5 Tubutecan Driving Superior Topo1 ADCs […]

xenon-pharma.com

A differentiated product pipeline for select high-need neuroscience indications.

apogeetherapeutics.com

Apogee Therapeutics is a clinical stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and immune (I&I) diseases with high unmet need

ascendispharma.com

Our Privacy Notice explains who we are, how we collect, share & use personal information about you, & how you can exercise your privacy rights in certain areas.

plustherapeutics.com

Plus Therapeutics is focused on developing innovative, targeted radiotherapeutics for adults & children with difficult-to-treat cancer. Leveraging novel drug formulations and technologies, our drugs are designed to deliver a single, safe and effective dose of radiation directly to the tumor

newdrugapprovals.org

National Medical Products Administration National Medical Products Administration (国家药品监督管理局) Formation 1950 (predecessor organization) 2018 (latest re-organization) Type Ministry-level regulatory …

dementiasplatform.uk

dementias platform uk is a high quality research environment. we make the translation from discoveries to therapeutics easier, better and faster.

imm.ox.ac.uk

the mrc weatherall institute of molecular medicine at the university of oxford was founded in 1989 by sir david weatherall to foster research in molecular and cell biology, with the aim of improving human health. through our excellent basic and applied research we have become leaders in translational medicine. our research has resulted in improved understanding, diagnosis and treatment of a wide range of human diseases.